KOMAL SHAH to Cell Differentiation
This is a "connection" page, showing publications KOMAL SHAH has written about Cell Differentiation.
Connection Strength
0.071
-
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial. J Clin Oncol. 2017 Oct 10; 35(29):3315-3321.
Score: 0.071